ITM-11 significantly improved progression-free survival over everolimus in GEP-NETs patients, marking a first for targeted radiopharmaceutical therapy in a phase 3 trial. The COMPETE trial included ...
What is the moon phase today? Today, Feb. 3, 2025, the moon is 5 days old, in the waxing crescent phase of its lunar cycle. It is 32% illuminated. Moon phases reveal the passage of time in the ...
Amgen still needs to show that the reduction in Lp(a) is accompanied by lower rates of cardiovascular outcomes, and will endeavour to show that in its phase 3 programme which will start to enrol a ...